ImmunoPrecise Antibodies Collaborates with FIND

IMMUNOPRECISE ANTIBODIES announces the publication for the development of a new TB diagnostic test.


Second US based office for ImmunoPrecise Antibodies

IMMUNOPRECISE ANTIBODIES announces opening of its second US based office in the Boston/Cambridge area.


ImmunoPrecise Antibodies Ltd. Increases Antibody Discovery Capabilities with Addition of Integrated Laboratory Equipment for High-throughput Antibody Screening

IMMUNOPRECISE ANTIBODIES has purchased its second state-of-the-art Intellicyt® iQue Screener PLUS for high-throughput cell-based screening, thereby increasing production volume.


ImmunoPrecise Appoints Lisa Helbling as Chief Financial Officer

IMMUNOPRECISE is excited to announce that it has appointed Lisa Helbling as CFO of the company.


Immunoprecise Doubles Q2 Revenue From Q2 2017

IMMUNOPRECISE ANTIBODIES doubles revenues in second quarter 2019.


ImmunoPrecise Antibodies Will Attend J.P. Morgan Healthcare Conference Week

Meet Jennifer Bath, CEO and President, Jason Orloske, Vice President of Operations, Frederick Chabot, Contact Financial, Paul Andreola, Board Director, and Pascal Nigen, Managing Partner at Alpha Bronze, at the J.P. Morgan Healthcare Conference Week.

Items 1 to 6 of 55 total

Show per page